🟢 Inovio Pharmaceuticals is trading 5.26% up today as conference announcement offers no clear catalyst

Inovio Pharmaceuticals is trading 5.26% up now at $1.40, but the specific reason for the September 2 move remains unclear.

• The company announced participation in the Cantor Global Healthcare Conference on September 9 and the H.C. Wainwright Global Investment Conference beginning September 11.
• The announcement provided no new clinical, regulatory, or financial catalyst, while broader markets are mixed.